Literature DB >> 10868716

Community-acquired pneumonia: development of a bedside predictive model and scoring system to identify the aetiology.

A Ruiz-González1, M Falguera, M Vives, A Nogués, J M Porcel, M Rubio-Caballero.   

Abstract

Although initial presentation has been commonly used to select empirical therapy in patients with community-acquired pneumonia (CAP), few studies have provided a quantitative estimation of its value. The objective of this study was to analyse whether a combination of basic clinical and laboratory information performed at bedside can accurately predict the aetiology of pneumonia. A prospective study was developed among patients admitted to the Emergency Department University Hospital Arnau de Vilanova, Lleida, Spain, with CAP. Informed consent was obtained from patients in the study. At entry, basic clinical (age, comorbidity, symptoms and physical findings) and laboratory (white blood cell count) information commonly used by clinicians in the management of respiratory infections, was recorded. According to microbiological results, patients were assigned to the following categories: bacterial (Streptococcus pneumoniae and other pyogenic bacteria), virus-like (Mycoplasma pneumoniae, Chlamydia spp and virus) and unknown pneumonia. A scoring system to identify the aetiology was derived from the odds ratio (OR) assigned to independent variables, adjusted by a logistic regression model. The accuracy of the prediction rule was tested by using receiver operating characteristic curves. One hundred and three consecutive patients were classified as having virus-like (48), bacterial (37) and unknown (18) pneumonia, respectively. Independent predictors related to bacterial pneumonia were an acute onset of symptoms (OR 31; 95% CI, 6-150), age greater than 65 or comorbidity (OR 6.9; 95% CI, 2-23), and leukocytosis or leukopenia (OR 2; 95% CI, 0.6-7). The sensitivity and specificity of the scoring system to identify patients with bacterial pneumonia were 89% and 94%, respectively. The prediction rule developed from these three variables classified the aetiology of pneumonia with a ROC curve area of 0.84. Proper use of basic clinical and laboratory information is useful to identify the aetiology of CAP. The prediction rule may help clinicians to choose initial antibiotic therapy.

Entities:  

Mesh:

Year:  2000        PMID: 10868716     DOI: 10.1053/rmed.1999.0774

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  6 in total

1.  A diagnostic rule for the aetiology of lower respiratory tract infections as guidance for antimicrobial treatment.

Authors:  A Willy Graffelman; Arie Knuistingh Neven; Saskia le Cessie; Aloys C M Kroes; Machiel P Springer; Peterhans J van den Broek
Journal:  Br J Gen Pract       Date:  2004-01       Impact factor: 5.386

2.  Evaluation of the Binax NOW Streptococcus pneumoniae urinary antigen assay in intensive care patients hospitalized for pneumonia.

Authors:  Sigismond Lasocki; Agnès Scanvic; Françoise Le Turdu; Aymeric Restoux; Hervé Mentec; Gérard Bleichner; Jean-Pierre Sollet
Journal:  Intensive Care Med       Date:  2006-09-07       Impact factor: 17.440

3.  Etiological analysis and predictive diagnostic model building of community-acquired pneumonia in adult outpatients in Beijing, China.

Authors:  Ya-Fen Liu; Yan Gao; Mei-Fang Chen; Bin Cao; Xiao-Hua Yang; Lai Wei
Journal:  BMC Infect Dis       Date:  2013-07-09       Impact factor: 3.090

4.  Biomarkers for iron metabolism among patients hospitalized with community-acquired pneumonia caused by infection with SARS-CoV-2, bacteria, and influenza.

Authors:  Maria Hein Hegelund; Andreas Glenthøj; Camilla Koch Ryrsø; Christian Ritz; Arnold Matovu Dungu; Adin Sejdic; Karoline Cecilie Knudsen List; Rikke Krogh-Madsen; Birgitte Lindegaard; Jørgen Anders Lindholm Kurtzhals; Daniel Faurholt-Jepsen
Journal:  APMIS       Date:  2022-07-18       Impact factor: 3.428

5.  Severe atypical pneumonia in critically ill patients: a retrospective multicenter study.

Authors:  S Valade; L Biard; V Lemiale; L Argaud; F Pène; L Papazian; F Bruneel; A Seguin; A Kouatchet; J Oziel; S Rouleau; N Bele; K Razazi; O Lesieur; F Boissier; B Megarbane; N Bigé; N Brulé; A S Moreau; A Lautrette; O Peyrony; P Perez; J Mayaux; E Azoulay
Journal:  Ann Intensive Care       Date:  2018-08-13       Impact factor: 6.925

Review 6.  Review of Non-Bacterial Infections in Respiratory Medicine: Viral Pneumonia.

Authors:  José María Galván; Olga Rajas; Javier Aspa
Journal:  Arch Bronconeumol       Date:  2015-05-07       Impact factor: 4.872

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.